Invitrogen™ Crizanlizumab Humanized Recombinant Human Monoclonal Antibody, 100 µg

Catalog No :

CAS Number :

Brand :

Availability :

In Stock

条款和条件
30天退款保证
运输:2-3 个工作日

    This combination does not exist.

    Place Inquiry

    This combination does not exist.

    Specifications:
    Application ELISA-Based Assays
    Storage Temperature -20°C
    Product Type Primary Antibodies Forms Lyophilized
    Product Brand Thermo Fisher Scientific™, Invitrogen
    Product Grade Molecular Biology

    The Invitrogen™ Crizanlizumab Humanized Recombinant Human Monoclonal Antibody is a high-purity biosimilar antibody targeting selectin P (SELP), expressed recombinantly in CHO cells.

    This antibody mimics the activity of the therapeutic monoclonal antibody Crizanlizumab, which blocks P-selectin-mediated interactions between endothelial cells, platelets, and leukocytes — key mechanisms underlying inflammation, vascular occlusion, and thrombosis.

    With >90% purity confirmed by SDS-PAGE analysis under both reducing and non-reducing conditions, this antibody is ideal for biochemical assays, ELISA, and biosimilar characterization related to P-selectin signaling pathways and adhesion molecule research.

    Key Features

    • Humanized IgG2κ Isotype: Ensures consistent specificity and reduced immunogenicity.
    • Biosimilar Specificity: Recognizes and binds to human P-selectin (SELP).
    • Recombinant Production: Expressed in CHO cells under serum-free, GMP-compliant conditions.
    • High Purity: >90% purity confirmed by SDS-PAGE analysis.
    • Low Endotoxin: <0.01 EU/µg by LAL method, suitable for sensitive functional studies.
    • Ready-to-Use Liquid Format: Supplied at 1 mg/mL for direct assay application.
    • Broad Application Range: Compatible with ELISA, SDS-PAGE validation, and P-selectin binding assays.

    Applications

    ApplicationRecommended Dilution
    ELISAAssay-dependent
    SDS-PAGEFor purity and structural verification

    Validated Example:

    SDS-PAGE analysis of recombinant human SELP protein (expressed in CHO cells) using Crizanlizumab biosimilar antibody (MA5-42133) revealed clear bands under both reducing (R) and non-reducing (NR) conditions, confirming antibody purity and structural integrity.

    Product Specifications

    ParameterSpecification
    Species ReactivityHuman
    Host/IsotypeHuman / IgG2, κ
    Expression SystemCHO (Chinese Hamster Ovary) Cells
    ClassRecombinant Monoclonal Antibody
    TypeHumanized Antibody
    ImmunogenHuman P-selectin (SELP)
    ConjugateUnconjugated
    FormLiquid
    Concentration1 mg/mL
    Purification MethodProtein A Affinity Chromatography
    Endotoxin Level< 0.01 EU/µg (LAL method)
    Storage BufferPBS, pH 7.4
    PreservativeNone
    Storage ConditionsShort-term: 2–8 °C (1 week); Long-term: –20 to –80 °C (12 months)
    Shipping ConditionsAmbient (domestic); Wet ice (international)
    RRIDAB_2911276

    Target Information – SELP (P-Selectin)

    Full Name: Selectin P (SELP)

    Function:

    • Mediates platelet–leukocyte and endothelial–leukocyte adhesion during inflammation and thrombosis.
    • Key regulator of vascular occlusion and inflammatory response.
    • Implicated in conditions such as sickle cell disease, atherosclerosis, and ischemic injury.

    Research Applications:

    • P-selectin ligand-binding and inhibition assays.
    • Platelet activation and adhesion studies.
    • Functional characterization of biosimilar antibodies.
    • Development of anti-inflammatory and anti-thrombotic therapeutics.

    Quality & Validation

    • Purity: Verified by SDS-PAGE (>90%).
    • Endotoxin: <0.01 EU/µg by LAL.
    • Recombinant Expression: CHO-based production ensures consistent quality and reproducibility.
    • Performance: Tested in ELISA and immunoassays targeting SELP.

    Storage and Handling

    • Storage: Store at –20 °C for up to 12 months. Avoid repeated freeze–thaw cycles.
    • Short-Term Use: Keep at 2–8 °C for up to 1 week.
    • Handling: Use a manual defrost freezer.
    • Format: Ready-to-use liquid, no reconstitution required.

    Advantages

    • Humanized recombinant IgG2κ antibody for SELP pathway research.
    • Low endotoxin level (<0.01 EU/µg) ensures compatibility with in vitro studies.
    • Verified purity and structure through SDS-PAGE.
    • Ideal for biosimilar, immunological, and vascular biology research.
    • Long-term stability and consistency under recommended storage conditions.

    The Invitrogen™ Crizanlizumab Humanized Recombinant Monoclonal Antibody is a biosimilar anti-P-selectin (SELP) antibody with humanized IgG2κ structure, expressed in CHO cells and purified to >90% by Protein A chromatography.

    With low endotoxin, unconjugated format, and high reproducibility, it serves as a reliable reagent for P-selectin functional studies, biochemical assays, and biosimilar validation workflows.

    Product Specification not found.

    Accessory Products


    Add a Review

    Rate this Product  
    Name *
    Email *

    Your Review *
    31996





    0

    0  Reviews
    (0) 
    (0) 
    (0) 
    (0) 
    (0) 

    Customer Review